ArticleJournal of Cancer2020

Comparison of Hypomethylator Monotherapy with Hypomethylator plus Chemotherapy for Intermediate/High-Risk MDS or AML: A Meta-Analysis.

Jiang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.